Apr Applied Pharma Research S.a.
Clinical trials sponsored by Apr Applied Pharma Research S.a., explained in plain language.
-
New PKU food shows promise in small trial
Disease control CompletedThis completed trial tested whether PKU GOLIKE, a special food for managing PKU, works better than standard amino acid protein substitutes at controlling blood phenylalanine levels. Sixteen children with PKU, aged 5 to 16, took part in a crossover study where they tried both prod…
Phase: NA • Sponsor: APR Applied Pharma Research s.a. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New liquid form of PKU drug tested for equivalence
Knowledge-focused CompletedThis study checks if a new liquid form of sapropterin (RLF-OD032) works the same as the approved powder (Kuvan) in 42 healthy adults. Participants receive a single dose of each version under fed conditions, and blood samples are taken to compare drug levels. The goal is to see if…
Phase: PHASE1 • Sponsor: APR Applied Pharma Research s.a. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC